Risk and Safety of Probiotics
Open accessThe DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.
Abstract
Probiotics have been used safely for years. Safety outcomes are inconsistently reported in published clinical trials. In 2011, a report released by the Agency for Healthcare Research and Quality concluded that, although the existing probiotic clinical trials reveal no evidence of increased risk, "the current literature is not well equipped to answer questions on the safety of probiotics in intervention studies with confidence." Critics point out that the preponderance of evidence, including the long history of safe probiotic use as well as data from clinical trials, and animal and in vitro studies all support the assumption that probiotics are generally safe for most populations. Theoretical risks have been described in case reports, clinical trial results and experimental models, include systemic infections, deleterious metabolic activities, excessive immune stimulation in susceptible individuals, gene transfer and gastrointestinal side effects. More research is needed to properly describe the incidence and severity of adverse events related to probiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although probiotics are widely used and generally considered safe for healthy individuals, accumulating evidence indicates that their safety profile varies significantly depending on the strain, dose, host, and context, with rare but clinically significant adverse events reported in vulnerable populations.”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Vulnerable populations (newborns, immunocompromised individuals, and critically ill individuals) are at greater risk; therefore, assessing regulatory compliance requires a combination of biochemical and metabolomic studies, whole genome sequencing for virulence, antibiotic resistance genes and motility mapping [63,66,87].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, in the same year, Doron et al. (2015) conducted an analysis based solely on traditional literature review methods based on the results of 622 probiotic safety studies [63].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with established guidance, probiotic safety is linked to intended use, strain identity, and historical evidence of safe exposure, and is distinct from classical pathogenic risk assessment.20-22”
From Safety and efficacy concerns in Indian probiotics: Insights from whole-genome sequencing and in vitro assessment (2026) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The presence of such ARGs and VFs may have clinical relevance, particularly in immunocompromised individuals or those with disrupted gut barriers, where opportunities for opportunistic infection or horizontal gene transfer may be increased.22,29-35”
From Safety and efficacy concerns in Indian probiotics: Insights from whole-genome sequencing and in vitro assessment (2026) · cites this paper as [22]
Experimental — accuracy not yet measured
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial
Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., & Isolauri, E. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04259-8 · Cited by 2,432 · cited 1×
“Pregnant women [19–21] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii None”
BackgroundBesselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., Nieuwenhuijs, V. B., Bollen, T. L., van Ramshorst, B., Witteman, B. J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60207-x · Cited by 1,367
Probiotics in the management of atopic eczema
Isolauri, E., Arvola, T., SÜtas, Y., Moilanen, E., & Salminen, S. (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00943.x · Cited by 974 · cited 1×
“Infants [15–18] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii, Bb12, L reuteri One mechanical choking episode reported”
BackgroundProbiotics: A novel approach in the management of food allergy
Majamaa, H., & Isolauri, E. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70093-9 · Cited by 918 · cited 1×
“Infants [15–18] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii, Bb12, L reuteri One mechanical choking episode reported”
BackgroundProbiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Goldenberg, J. Z., Ma, S. S., Saxton, J. D., Martzen, M. R., Vandvik, P. O., Thorlund, K., Guyatt, G. H., & Johnston, B. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006095.pub3 · Cited by 741
Lactobacillus Sepsis Associated With Probiotic Therapy
Land, M. H., Rouster-Stevens, K., Woods, C. R., Cannon, M. L., Cnota, J., & Shetty, A. K. (2005) · Pediatrics · doi:10.1542/peds.2004-2137 · Cited by 599 · cited 1×
“Nine cases of overt sepsis have been reported [57–63], asso-”
BackgroundKhalesi, S., Sun, J., Buys, N., & Jayasinghe, R. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03469 · Cited by 516
Rayes, N., Seehofer, D., Theruvath, T., Schiller, R. A., Langrehr, J. M., Jonas, S., Bengmark, S., & Neuhaus, P. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00649.x · Cited by 478 · cited 2×
“Immunocompromised [12–14] Pediacoccus pentosaceus, Leuconostoc mesenteroides, Lactobacillus paracasei subspecies paracasei F19, Lactobacillus plantarum, LGG, L.”
BackgroundRayes, N., Seehofer, D., Hansen, S., Boucsein, K., M??ller, A. R., Serke, S., Bengmark, S., & Neuhaus, P. (2002) · Transplantation · doi:10.1097/00007890-200207150-00021 · Cited by 476 · cited 2×
“Immunocompromised [12–14] Pediacoccus pentosaceus, Leuconostoc mesenteroides, Lactobacillus paracasei subspecies paracasei F19, Lactobacillus plantarum, LGG, L.”
Background
Research works printed but not linked: 3
- Kukkonen, 2008, Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial, Pediatrics, 122, 8, 10.1542/peds.2007-1192 · DOI · Paper page
- Trautmann, 2008, Fungemia due to Saccharomyces cerevisiae var. boulardii, Chemother J, 17, 57
- Lestin, 2003, Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities, Dtsch Med Wochenschr, 128, 2531
Cited by
Items 401–500 of 1,000
Unveiling The Therapeutic Potential of Probiotics: A Review
Tukaram, K. S., Sopanrao, S. R., & Kacharu, L. O. (2025) · Journal of Future Foods · doi:10.1016/j.jfutfo.2025.09.011 · Cited by 19
Sabouri, S., Esmailzadeh, M., Sadeghinejad, A., Shahrbabaki, M. E., Asadikaram, G., & Nikvarz, N. (2022) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000660 · Cited by 19
Dahmouni, S., Benabdelmoumene, D., Bengharbi, Z., Fodil, M. K., Umar, K., Qadi, W. S. M., Krache, F., Waqar, M., Tong, X., Han, R., et al. (2026) · npj Science of Food · doi:10.1038/s41538-026-00838-z · Cited by 19
Mahalak, K. K., Firrman, J., Tolehmurodovich, B. J., Narrowe, A. B., Bittinger, K. L., Daniel, S. G., Tanes, C., Mattei, L. M., Zeng, W.-B., Soares, J. W., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112973 · Cited by 19
“gastroenteritis [26], ileal pouch inflammation [27], and increased incidence of bacteremia, endocarditis, and sepsis-induced dysbiosis [3,28].”
BackgroundRittiphairoj, T., Pongpirul, K., Mueller, N. T., & Li, T. (2019) · Systematic Reviews · doi:10.1186/s13643-019-1145-y · Cited by 19
Ramakrishna, K., Anusha, V. L., & Krishnamurthy, S. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105823 · Cited by 19
Gastrointestinal worms and bacteria: From association to intervention
Rooney, J., Cantacessi, C., Sotillo, J., & Cortés, A. (2022) · Parasite Immunology · doi:10.1111/pim.12955 · Cited by 19
“The main positive and negative aspects currently associated with each microbiome-targeting or bacteria-based intervention strategy are summarized directly under each panel.(58,109,110) ROONEY ET AL.”
BackgroundZhao, Z., Li, W., Tran, T. T., & Loo, S. C. J. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03263-y · Cited by 19
“For a long period, lactic acid bacteria (LAB) such as Lacto-bacillus , Lactococcus, Streptococcus and Bifidobacterium have been considered to be safe for use [3–5].”
BackgroundZhang, Y., Cao, T., Wang, Y., Yang, R., Han, Y., Li, S., Liu, D., Yue, Y., Cao, Y., Li, B., et al. (2024) · Foods · doi:10.3390/foods13060958 · Cited by 19
“However, some studies suggested that probiotics have certain side effects on the treatment of colon cancer, such as causing gastrointestinal disorders in colon cancer patients (bloating, ecological imbalance of gut microbiota and the spread of resistance genes between gut microbiota) [12].”
BackgroundBouferraa, Y., Chedid, A., Amhaz, G., Lakkiss, A. E., Mukherji, D., Temraz, S. N., & Shamseddine, A. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158036 · Cited by 18
Song, H., Hu, W., Zhou, X., Tao, J., Zhang, S., Su, X., & Wu, W. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.798827 · Cited by 18
“However, several studies have described the potential risks of probiotics such as systemic infections, deleterious metabolic activities, excessive immune stimulation in susceptible individuals, gene transfer, and gastrointestinal side effects (14, 15).”
BackgroundResultFrom germ theory to germ therapy
Chen, C., Chen, Y., Liou, J., & Wu, M. (2019) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12011 · Cited by 18
“However, there were still a number of case reports showing theoretical risks including systematic infections, deleterious metabolic activities, excessive immune status.(97) Probiotics and related supplement appeared to be well tolerated in most of the trials.”
BackgroundYang, J., Huang, J., Huang, Z., Xu, Y., Li, W., Zhu, S., Zhao, Y., Ye, B., Liu, L., Zhu, J., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.07.017 · Cited by 18
The mechanisms and safety of probiotics against toxigenic clostridium difficile
Liu, D., Zeng, L., Yan, Z., Jia, J., Gao, J. X., & Wei, Y. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1778464 · Cited by 18
Lee, Y.-S., Yu, H.-Y., Kwon, M., Lee, S., Park, J., Seo, J., & Kim, S.-K. (2023) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2211.11029 · Cited by 18
“Safety Assessment of the Antibiotic Resistance of KGC1201 In rare cases, probiotics can cause side effects in the gastrointestinal tract [29].”
Gut microbiota implication in diabetic kidney disease: mechanisms and novel therapeutic strategies
Zhang, Y., Qing, J., Saed, Y. A., & Li, Y. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2517402 · Cited by 18
“…colonization in DKD patients remains uncertain, particularly in immunocompromised individuals, where probiotics may pose a potential infection risk [151]. one of the key limitations in gut microbiota studies is the lack of standardized methodologies across different research efforts. to enhance…”
Exploring the Role of Gut Microbiota and Probiotics in Acute Pancreatitis: A Comprehensive Review
Nista, E. C., Parello, S., Brigida, M., Amadei, G. A., Saviano, A., Lucia, S. S. D., Petruzziello, C., Migneco, A., & Ojetti, V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073433 · Cited by 18
“Further complicating this process, there is a lack of standardization for donor screening, preparation, and storage [146,150].”
Small at Size, Big at Impact: Microorganisms for Sustainable Development
Singh, N., Singh, J., & Singh, K. (2018) · Springer eBooks · doi:10.1007/978-981-13-0053-0_1 · Cited by 18
Nawab, A., Liu, W., LI, G., Ibtisham, F., FOX, D. P., Yi, Z., WO, J., Xiao, M., NAWAB, Y., & An, L. (2019) · Journal of the Hellenic Veterinary Medical Society · doi:10.12681/jhvms.19600 · Cited by 18
Lee, Y., Seo, H., Kim, S., Rahim, M. A., Yoon, Y., Jung, J., Lee, S., Ryu, C. B., & Song, H. (2021) · The Journal of Microbiology · doi:10.1007/s12275-021-1332-0 · Cited by 17
Lima, M., & Paulino, L. C. (2023) · Journal of the American Nutrition Association · doi:10.1080/27697061.2023.2232021 · Cited by 17
Safety Evaluation of a Novel Potentially Probiotic Limosilactobacillus fermentum in Rats
Neto, J. P. R. C., de Oliveira, A. M., de Oliveira, K. Á. R., Sampaio, K. B., Dutra, M. L. D. V., Freire, M. O. D. L., de Souza, E. L., & Alves, J. L. D. B. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10077-3 · Cited by 17
“…safety is still characterized by a paucity of studies specifically designed for this purpose [50], and that investigators conducting clinical trials with probiotics could actively monitor cases of infections associated with probiotic consumption and the occurrence of other adverse effects [23].”
A review for non-antibiotic treatment of Helicobacter pylori: new insight
Shadvar, N., Akrami, S., Mousavi-Sagharchi, S. M. A., Askandar, R. H., Merati, A., Aghayari, M., Kaviani, N., Afkhami, H., & Kashfi, M. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1379209 · Cited by 17
“Individuals suffering from immunodeficiency, heart valve disease, short bowel syndrome, or preterm newborns are at risk of severe responses and should avoid using these items (Doron and Snydman, 2015; Singhi and Kumar, 2016).”
BackgroundAn Insight into the Combination of Probiotics and their Implications for Human Health
Hmar, E. B. L., Paul, S., & Sharma, H. K. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230502141717 · Cited by 17
Commercially Available Probiotics and Prebiotics Used in Human and Animal Nutrition
Muzaffar, K., Jan, R., Bhat, N. A., Gani, A., & Shagoo, M. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822909-5.00025-3 · Cited by 17
Ari, M. M., Mirkalantari, S., Darban‐Sarokhalil, D., Darbandi, A., Razavi, S., & Talebi, M. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1383959 · Cited by 17
“Despite the safety history of probiotics for clinical application, a rarely occurring bacteremia in high-risk individuals was reported following consumption of probiotics (Doron and Snydman, 2015).”
BackgroundCimini, D., D’ambrosio, S., Stellavato, A., Fusco, A., Corsaro, M. M., Dabous, A., Casillo, A., Donnarumma, G., Giori, A. M., & Schiraldi, C. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1007004 · Cited by 17
“experimental models, systemic infections, deleterious metabolic activities, excessive immune stimulation in susceptible individuals, gene transfer and gastrointestinal side effects) (Doron and Snydman, 2015).”
BackgroundTreatment management for rosacea: current pharmacological and non-pharmacological options
Volk, K., Ulfers, A., Yi, R. C., Feldman, S. R., & Taylor, S. L. (2025) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2025.2550727 · Cited by 17
“In rare cases, particularly in the immuno-compromised demographic, cases of fungemia, bacteremia, or sepsis have been reported [76].”
Zidan, D., Sabran, M. R., Ramli, N. S., Shafie, S. R., & Fikry, M. (2021) · International Journal of Food Science & Technology · doi:10.1111/ijfs.14956 · Cited by 17
Assessment of the safety of “probiotics” in food supplements
Motherway, M. O., O’Connor, L. M., Smith, S. A., Bolton, D., Cormican, M., Waal, T. D. D., Gutiérrez, M., Part, A. M., Walsh, F., & Duffy, G. (2024) · Food Risk Assess Europe · doi:10.2903/fr.efsa.2024.fr-0050 · Cited by 16
Mitra, A. K., Asala, A. F., Malone, S., & Mridha, M. K. (2023) · Diseases · doi:10.3390/diseases11040138 · Cited by 16
“Several studies described and warned about major safety issues in using probiotics, including, but not limited to, systemic infections, deleterious metabolic activities, excessive immune stimulation in susceptible individuals, gene transfer and gastrointestinal side effects [62,63].”
BackgroundExopolysaccharides Derived from Probiotic Bacteria and their Health Benefits
Bhandary, T., Kurian, C., Muthu, M., Anand, A., Anand, T., & Paari, K. A. (2023) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.17.1.40 · Cited by 16
(2023) · Biointerface Research in Applied Chemistry · doi:10.33263/briac135.476 · Cited by 16
Prebiotic prophylaxis of ventilator-associated pneumonia: A randomized clinical trial
Kooshki, A., Khazaei, Z., Zarghi, A., Rad, M., & Tabarraie, Y. (2018) · Biomedical Research and Therapy · doi:10.15419/bmrat.v5i5.442 · Cited by 16
“Probiotics may be ineffective before persisting in the lower digestive tract [6,7].”
BackgroundESKAPEE Pathogen Biofilm Control on Surfaces with Probiotic Lactobacillaceae and Bacillus species
Neidhöfer, C., Rathore, K., Parčina, M., & Sieber, M. A. (2023) · Antibiotics · doi:10.3390/antibiotics12050871 · Cited by 15
Analysis of interactions of immune checkpoint inhibitors with antibiotics in cancer therapy
Li, Y., Wang, S., Lin, M., Hou, C., Li, C., & Li, G. (2022) · Frontiers of Medicine · doi:10.1007/s11684-022-0927-0 · Cited by 15
Therapeutic implications of the gastrointestinal microbiome
Kashyap, P., & Quigley, E. M. M. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.01.004 · Cited by 15
Probiotics as a Complementary Medicine in Neurologic Disorders
Jafari, M., Alipour, M., Zamani, S., Amiri, A. M., Pourabbas, P., & Bibalan, M. H. (2025) · Health Science Reports · doi:10.1002/hsr2.71422 · Cited by 15
“However, probiotics offer distinct advantages including a favorable safety profile with minimal adverse effects and may be particularly valuable for patients who are reluctant to use or unable to tolerate conventional medications [42, 43].”
Probiotics: health safety considerations
Borase, H. P., Dwivedi, M., Krishnamurthy, R., & Patil, S. V. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823733-5.00020-9 · Cited by 15
Hasan, F. B., Reza, M., Masud, H. M. A. A., Uddin, M. K., & Uddin, M. S. (2019) · Bangladesh Journal of Microbiology · doi:10.3329/bjm.v36i1.44259 · Cited by 15
Hyun, D., Lee, J., Kim, M., Shin, N.-R., Whon, T. W., Kim, K. H., Kim, P. S., Tak, E. J., Jung, M., Lee, J., et al. (2021) · The Journal of Microbiology · doi:10.1007/s12275-021-1165-x · Cited by 15
Craighead, A. F., Caughey, A. B., Chaudhuri, A., Yieh, L., Hersh, A. R., & Dukhovny, D. (2020) · Journal of Perinatology · doi:10.1038/s41372-020-00790-0 · Cited by 15
Warma, S., Lee, Y. L., Brietzke, E. M., & McIntyre, R. S. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104640 · Cited by 15
Strategies for the treatment of colorectal cancer caused by gut microbiota
de Souza, J. B., de Castro, M. C. A. B., & Cavalcanti, I. M. F. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120202 · Cited by 15
Bai, T., Zeng, H., Long, Y., Li, X., Sun, X., Lan, Y., Gao, L., Zhang, L., Feng, Z., & Hou, X. (2020) · Trials · doi:10.1186/s13063-020-04490-0 · Cited by 15
Chen, J., Liang, H., Lu, J., He, Y., & Lai, R. (2022) · Nutrition and Cancer · doi:10.1080/01635581.2022.2056619 · Cited by 15
“World Health Organization and the Food and Agriculture Organization of the United Nations concerned that probiotics may be responsible for systemic infections, deleterious metabolic activities, excessive immune stimulation in susceptible individuals and gene transfer (31).”
BackgroundPremature rupture of membranes and changes in the vaginal microbiome – Probiotics
Gorczyca, K., Kozioł, M. M., Kimber-Trojnar, Ż., Kępa, J., Satora, M., Rekowska, A. K., & Leszczyńska‐Gorzelak, B. (2024) · Reproductive Biology · doi:10.1016/j.repbio.2024.100899 · Cited by 15
Luenglusontigit, P., Sathapondecha, P., Saengsuwan, P., Surachat, K., Boonserm, P., & Singkhamanan, K. (2023) · Journal of Health Science and Medical Research · doi:10.31584/jhsmr.2023918 · Cited by 15
Łętocha, A., Michalczyk, A. K., Bielecka, E., Kantyka, T., Miastkowska, M. A., & Sikora, E. S. (2025) · Scientific Reports · doi:10.1038/s41598-025-16273-1 · Cited by 15
STOUGAARD, E. B., Tougaard, N. H., Sivalingam, S., Hansen, C. S., Størling, J., Hansen, T. W., Frimodt‐Møller, M., Steinert, R. E., Varasteh, S., Groop, P., et al. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108892 · Cited by 15
Zhou, X., Zheng, W., Kong, W., Zhang, J., Liao, Y., Min, J., & Zeng, T. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf340 · Cited by 14
Nobre, L. M. S., Fernandes, C., Florêncio, K. G. D., de Alencar, N. M. N., Wong, D. V. T., & Lima‐Júnior, R. C. P. (2022) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2022e12522 · Cited by 14
“According to a report jointly published by the World Health Organization (WHO) and the Food and Agriculture Organization of the United Nations (FAO), probiotics can be responsible for four types of side effects: systemic infections, harmful metabolic activities, gene transfer, and excessive immune stimulation in susce…”
MethodModulating the Gut Microbiome in Type 2 Diabetes: Nutritional and Therapeutic Strategies
Nikolaidis, C. G., Gyriki, D., Stavropoulou, E., Karlafti, E., Didangelos, T., Tsigalou, C., & Thanopoulou, A. C. (2025) · Nutrients · doi:10.3390/nu18010089 · Cited by 14
“The major side effects associated with probiotics involve gastrointestinal effects that are self-limited, skin reactions, stimulation of immune responses, metabolic disturbances, systemic infections (bacteremia, fungemia), sepsis, and endocarditis [48].”
In inflammatory bowel disease and extraintestinal manifestations: What role does microbiome play?
Shen, Y., Zhu, H., Zhou, L., Zheng, Y.-Q., Zhang, Z., Xie, Y., Liu, Z., Peng, C., Wang, L., Zhao, C., et al. (2023) · Engineered Regeneration · doi:10.1016/j.engreg.2023.04.005 · Cited by 14
The New Proactive Approach and Precision Medicine in Crohn’s Disease
Zittan, E., Gralnek, I. M., & Berns, M. S. (2020) · Biomedicines · doi:10.3390/biomedicines8070193 · Cited by 14
Khoury, S. E., Gauthier, J., Mercier, P.-L., Moïse, S., Giovenazzo, P., & Derôme, N. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00578-24 · Cited by 14
“In terms of commercial microbial supplementation, some strains have been reported to cause dysbiosis, resulting in an imbalance between microbiota and host (43, 44).”
Laslo, É., György, É., & Czikó, A. (2019) · Acta Universitatis Sapientiae Alimentaria · doi:10.2478/ausal-2019-0004 · Cited by 14
“The safety characterization of LAB is essential to avoid any risk of infection by using them (Borriello et al., 2003, Doron and Snydman, 2015).”
Lu, M., Hsu, C., Lo, H.-C., Chang, H.-H., & Koo, M. (2022) · Medicina · doi:10.3390/medicina58070944 · Cited by 14
“The reduction could possibly be related to the concern of stimulating the immune response by probiotics [33,34].”
BackgroundIn vitro assessment of histamine and lactate production by a multi-strain synbiotic
Stuivenberg, G. A., Daisley, B. A., Akouris, P. P., & Reid, G. (2021) · Journal of Food Science and Technology · doi:10.1007/s13197-021-05327-7 · Cited by 14
“9 million people consume probiotics daily, in the US alone, only * 5 cases of probiotic associated D-lactic acidosis have been reported to date (Doron and Snydman 2015).”
BackgroundInfluentialJeong, S.-G., Kim, H. M., Lee, M., Yang, J. E., & Park, H. W. (2022) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2210.10049 · Cited by 13
“Although several genera of LAB have been developed as functional probiotics, safety concerns regarding the consumption of probiotics have been raised due to the possibility of side effects caused by the unexpected activity of live microorganisms [12, 13].”
BackgroundPérez‐Cantero, A., Thomson, P., Paredes, K., Guarro, J., & Capilla, J. (2019) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2018.04.004 · Cited by 13
Türkiye'deki Eczanelerde Bulunan Probiyotiklere Genel Bakış
Korkut, O., & Şen, F. (2022) · Balıkesır Health Sciences Journal · doi:10.53424/balikesirsbd.1115356 · Cited by 13
The role of probiotics in promoting systemic immune tolerance in systemic lupus erythematosus
Mohamed, A. H., Shafie, A., Al-Samawi, R. I., Jamali, M. C., Ashour, A. A., Felemban, M. F., Alqarni, A., Ahmad, I., Mansuri, N., Ahmad, F., et al. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00702-7 · Cited by 13
“As identified probiotic microorganisms, class of lactic acid bacteria (LAB), for example, Lactococcus, Streptococcus, Lactobacillus, and Enterococcus, as well as Bifidobacterium, have an extended history of safe usage [76, 77].”
Neto, J. V., Chella, T. P., Rudnik, D. P., & Ribeiro, S. M. L. (2020) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.202000000-06 · Cited by 13
“The use of this type of substance by “apparently healthy” individuals is scarcely investigated in the literature, and at the same time, broadly recommended at clinical practice(22-24).”
BackgroundBratcher, D. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00133-x · Cited by 13
Review: Probiotics in dermatology
Sudhamani, B. (2019) · Journal of Skin and Sexually Transmitted Diseases · doi:10.25259/jsstd_18_2019 · Cited by 13
Vale, G. C., Mota, B. I. S., Ando‐Suguimoto, E. S., & Mayer, M. P. A. (2021) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09832-1 · Cited by 13
Siragusa, N., Baldassari, G., Ferrario, L., Passera, L., Rota, B., Pavan, F., Santagata, F., Capasso, M., Londoni, C., Manfredi, G., et al. (2025) · Nutrients · doi:10.3390/nu17152496 · Cited by 12
“Overall, probiotics are effective, safe, well-tolerated, and well-recommended for treating different types of IBS, but only for a limited time, although further confirmation from more studies is still needed [190].”
The Handbook of Wellness Medicine
Snellings, J. E. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182 · Cited by 12
Yang, Y., Zhang, Y., Sun, R., Du, W., Liu, Y., Zheng, L., Ren, Z., Li, M. D., & Xu, J. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10498-2 · Cited by 12
“The safety of a probiotic strain is always a critical issue in parallel to its health benefits [38, 39].”
Kong, L., Hu, X., Xia, D., Wu, J., Zhao, Y., Guo, H., Zhang, S., Qin, C., Wang, Y., Li, L., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.123060 · Cited by 12
Zhang, C., Xi, Y., Zhang, Y., He, P., Su, X., Li, Y., Zhang, M., Liu, H., Xiao, Y., & Shi, Y. (2024) · Heart & Lung · doi:10.1016/j.hrtlng.2024.01.002 · Cited by 12
Ma, J., & Dubberke, E. R. (2018) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.4377 · Cited by 12
Li, Y., Gao, J., Xue, L., Shang, Y., Cai, W., Xie, X., Jiang, T., Chen, H., Zhang, J., Wang, J., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.812623 · Cited by 12
“Safety and gastrointestinal tolerance are two important factors to consider when evaluating LAB strains as potential probiotics (68).”
BackgroundRegulation of allergies across the body by microbial metabolites
Kim, C. H., & Baker, J. R. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01642-1 · Cited by 12
“Major examples are potential infections and in fl ammatory responses, particularly in the urogenital sys-tem 180,181 .”
Local Bacteriotherapy – a promising preventive tool in recurrent respiratory infections
Ciprandi, G., Mantia, I. L., Damiani, V., & Passàli, D. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1833720 · Cited by 12
Nejati, R., Nematollahi, A., Doraghi, H. K., Sayadi, M., & Alipanah, H. (2023) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13945 · Cited by 12
“43 The testicular and renal SOD activities are shown in Tables 1 and 2.”
BackgroundIn-vitro and preclinical testing of bacillus subtilis UBBS-14 probiotic in rats shows no toxicity
Negi, A., Pasam, T., Farqadain, S. M., Mahalaxmi, Y., & Dandekar, M. P. (2024) · Toxicology Research · doi:10.1093/toxres/tfae021 · Cited by 12
Quest for Alternatives to Antibiotics: An Urgent Need of the Twenty-First Century
Adhikari, M. D., Saha, T., & Tiwary, B. K. (2022) · Springer eBooks · doi:10.1007/978-981-19-1854-4_1 · Cited by 12
Patz, S., Witzel, K., Scherwinski, A., & Ruppel, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153661 · Cited by 12
Anwar, M., Mros, S., McConnell, M. A., & Bekhit, A. E. A. (2022) · Nutrients · doi:10.3390/nu14102128 · Cited by 12
Postbiotics in Poultry Nutrition: Mechanisms of Action, Health Benefits and Future Perspectives
Biagini, L., Muollo, M. C., Galosi, L., Roncarati, A., Bellis, D. D., & Rossi, G. (2026) · Agriculture · doi:10.3390/agriculture16030387 · Cited by 12
“However, concerns have been raised by international health authorities (WHO, FAO) regarding their safety, stability, strain viability, and the potential horizontal transfer of antimicrobial resistance genes [9,10], especially for their application in livestock production.”
Antioxidant and anti-stress properties of postbiotics produced by Lysinibacillus macroides G117
Qiao, S., Lv, C., Zhang, X., Lv, X., Yang, D., & Zhao, J. (2024) · Comparative Immunology Reports · doi:10.1016/j.cirep.2024.200143 · Cited by 12
“The theoretical risks of live probiotic bacterial administration, including systemic infections, deleterious metabolic activities, excessive immune stimulation, gene transfer, and gastrointestinal side effects have been described in case reports, clinical trials, and experimental models [4].”
BackgroundProbiotics in critically ill patients: An umbrella review
Mahmoodpoor, A., Sanaie, S., Naseri, A., & Seyedi-Sahebari, S. (2022) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24129 · Cited by 11
Bénéfices et risques des compléments alimentaires
Crenn, P. (2020) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2020.04.006 · Cited by 11
Probiotics for caries prevention: A narrative review
Nizami, M. Z. I., Chu, S., Chu, S., & Chu, C. H. (2025) · Journal of Applied Biomaterials & Functional Materials · doi:10.1177/22808000251376427 · Cited by 11
“87 Strain specificity is critical, as certain Lactobacillus species, such as Lactobacillus acidophilus (L. acidophilus ), possess aci-dogenic traits that could inadvertently exacerbate caries.”
Intestinal microecology-based treatment for inflammatory bowel disease: Progress and prospects
Yan, X.-X., & Dong, W. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i1.47 · Cited by 11
Dubé‐Zinatelli, E., Cappelletti, L., & Ismail, N. (2025) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2025.104804 · Cited by 11
Kong, Q., Shang, Z., Nawaz, S., Liu, S., & Li, J. (2024) · Nutrients · doi:10.3390/nu16121900 · Cited by 11
“Unfortunately, various case reports of probiotic-associated bacteremia, fungemia, endocarditis, liver abscess, and pneumonia have been published, even though the ingested probiotics are known to possess low-virulent and nonpathogenic properties [42].”
BackgroundAlaei, A., Mahmoudi, M., Sahebari, M., Vahidi, Z., Tabasi, N. S., & Rastin, M. (2023) · Archives of Rheumatology · doi:10.46497/archrheumatol.2023.9941 · Cited by 11
Joung, H., Chu, J., Kwon, Y. J., Kim, K. H., Shin, C. H., & Ha, J. (2024) · Applied Biological Chemistry · doi:10.1186/s13765-024-00949-9 · Cited by 11
Safety Evaluation of Lactic Acid Bacteria
Chen, W., Yu, L., & Shi, Y. (2019) · Springer eBooks · doi:10.1007/978-981-13-7832-4_11 · Cited by 11
Zhao, Y., Zhang, H., Zhao, Z. J., Liu, F., Dong, M., Chen, L., Shen, M., Luan, Z., Zhang, H., Wu, J., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29035 · Cited by 11
“of special interest (gastrointestinal related adverse reactions, infection, harmful metabolic effects, grade ≥1).(20) Safety data is obtained through daily monitoring of AEs from the first day of treatment through 14 days following cessation of treatment.”
BackgroundEffect of Probiotics on Full Intestinal Feeding in Premature Infants: A Double Blind, Clinical Trial
Jalali, S. Z., shiri, M. R., & Shirazi, M. G. (2020) · Iranian Journal of Pediatrics · doi:10.5812/ijp.100139 · Cited by 11
Roberto, M., Carconi, C., Cerreti, M., Schipilliti, F. M., Botticelli, A., Mazzuca, F., & Marchetti, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.704942 · Cited by 10
Does the Maternal Gut Microbiome Influence the Outcome of Perinatal Asphyxia?
Morozan, V.-P., Ionescu, M.-I., Zahiu, C. D. M., Catrina, A. M., Racoviță, A., Chirilă, A.-T., Dogaru, I.-A., Ciotei, C., Pîrcălăbioru, G. G., & Zăgrean, A. (2025) · Antioxidants · doi:10.3390/antiox14091134 · Cited by 10
“Although many probiotics contain strains that are naturally present in the human gut or used in fermented foods, such as Lactobacillus , Bifidobacterium , Streptococcus , Saccharomyces , and Bacillus , their safety in vulnerable populations remains incompletely understood [287].”
Advice to People with Parkinson’s in My Clinic: Probiotics and Prebiotics
Hor, J. W., Toh, T. S., Lim, S., & Tan, A. H. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-240172 · Cited by 10
Fernández‐Lázaro, D., Sánchez-Serrano, N., Rabail, R., Aadil, R. M., Mielgo‐Ayuso, J., Radesca, K., & Garrosa, E. (2023) · Applied Sciences · doi:10.3390/app13063448 · Cited by 10
Fernández, L., Orgaz, B., & Rodríguez, J. M. (2024) · Foods · doi:10.3390/foods13244024 · Cited by 10
Lin, Y., Chen, Y., & Chen, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208881 · Cited by 10
Metadata
- Authors
- Doron, S., & Snydman, D. R.
- Affiliations
- Tufts Medical Center (US)
- Corresponding author
- Doron, Shira
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04-28
- Volume
- 60
- Issue
- suppl_2
- Pages
- S129-S134
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC4490230
- OpenAlex
- W2027617880
- Cited by
- 942
- References
- 91
- Citations by year
- 2026: 89 · 2025: 105 · 2024: 112 · 2023: 105 · 2022: 99 · 2021: 100 · 2020: 135 · 2019: 85 · 2018: 55 · 2017: 32 · 2016: 18 · 2015: 7
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k23at003391-03)
- National Center for Complementary and Integrative Health (K23 AT-003391, 5K23 AT003391-03)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, probiotic safety, adverse events, systemic infection, immunostimulation, gene transfer, gastrointestinal adverse effects, risk assessment
- MeSH terms
- Clinical Trials as Topic, Humans, Lactobacillus, Risk, Saccharomyces, United States, Fungemia, Sepsis, Probiotics, Gene Transfer, Horizontal, Gastrointestinal Tract
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.